Secrets, Scripts, and Skinny Labels: The 2025 IP Shocks Now Driving 2026 Strategy
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Secrets, Scripts, and Skinny Labels: The 2025 IP Shocks Now Driving 2026 Strategy
-
Narrated by:
-
By:
About this listen
Episode 14 of Paralegal’s Memo with Winn Trivette II breaks down how recent trade secret and pharma “skinny label” decisions are reshaping 2026 IP strategy for paralegals and junior practitioners. It explains how the Defend Trade Secrets Act can extend across borders (highlighting Insulate v. EOFlow), notes major damages risk in cases like Zest Labs v. Walmart and ZN0 v. Boeing, and shows how non-traditional assets and looser pre-discovery identification rules can broaden what may qualify as a trade secret (PleaserDAO v. Rakel and Quintara Biosciences).
Let's Connect:
LinkedIn
X.com
YouTube
Subscribe to Paralegal's Memo on LinkedIn
Don’t forget to subscribe to the print version of Paralegal’s Memo on LinkedIn — you’ll find it at bit.ly/paralegal101.
Disclaimer: This podcast is for informational purposes only and nothing should be construed as legal advice. That’s why you must always consult a qualified attorney.